Dec 9, 2013 : Bharat Book Bureau presents the new report, on ''Thrombus 2007-2013" provides understanding and access to the thrombus partnering deals and agreements entered into by the worlds leading healthcare companies.
Thrombus Partnering 2007-2013 report provides understanding and access to the thrombus partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in thrombus partnering deals
Top thrombus deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides an analysis of thrombus partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors thrombus technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains over 50 links to online copies of actual thrombus deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of thrombus partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in thrombus partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading thrombus deals since 2007. Deals are listed by headline value, signed by bigpharma, most active all bio pharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of thrombus partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to
know about partnering in the research, development and commercialization of
thrombus technologies and products.
Thrombus Partnering 2007-2013 is intended to provide the reader with an in-depth understanding and access to thrombus trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
Trends in thrombus dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
Access to over 50 thrombus contract documents
The leading thrombus deals by value since 2007
In Thrombus Partnering 2007-2013, the available deals are listed by:
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Thrombus Partnering 2007-2013 provides the reader with the following key benefits:
In-depth understanding of thrombus deal trends since 2007
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 50 actual thrombus deals entered into by the world’s biopharma companies since 2007
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Table of Contents:
Chapter 1 – Introduction
Chapter 2 – Trends in thrombus partnering
2.2. Thrombus partnering over the years
2.3. Bigpharma thrombus dealmaking activity
2.4. Thrombus partnering by deal type
2.5. Thrombus partnering industry sector
2.6. Thrombus partnering by stage of development
2.7. Thrombus partnering by technology type
2.8. Disclosed financial deal terms for thrombus partnering
2.8.1 Thrombus headline values
2.8.2 Thrombus upfront payments
2.8.3 Thrombus milestone payments
2.8.4 Thrombus royalty rates
For more information kindly visit : http://www.bharatbook.com/Healthcare-market-research-reports/Thrombus-2007-2013.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: https://twitter.com/researchbook
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.